FDA Determines Regulatory Review Period for RESQCPR SYSTEM Patent Extension

Summary

The U.S. Food and Drug Administration (FDA) has officially announced its decision on the regulatory review period for RESQCPR SYSTEM, a medical device patent extension application submitted to the U.S. Patent and Trademark Office (USPTO).